CDR3 Variants of the TXB2 Shuttle with Increased TfR1 Association Rate and Enhanced Brain Penetration.
Stocki P, Szary J, Demydchuk M, Northall L, Rasmussen CLM, Logan DB, Gauhar A, Thei L, Coker SF, Moos T, Walsh FS, Rutkowski JL.
Stocki P, et al. Among authors: logan db.
Pharmaceutics. 2023 Feb 23;15(3):739. doi: 10.3390/pharmaceutics15030739.
Pharmaceutics. 2023.
PMID: 36986599
Free PMC article.